tiprankstipranks
KalVista price target lowered to $33 from $35 at JonesResearch
PremiumThe FlyKalVista price target lowered to $33 from $35 at JonesResearch
2M ago
KalVista Pharmaceuticals Reports Progress in HAE Treatment
Premium
Company Announcements
KalVista Pharmaceuticals Reports Progress in HAE Treatment
2M ago
KalVista reports Q2 EPS (91c), consensus (91c)
Premium
The Fly
KalVista reports Q2 EPS (91c), consensus (91c)
2M ago
KalVista Secures $184M Financing for Sebetralstat Launch
PremiumCompany AnnouncementsKalVista Secures $184M Financing for Sebetralstat Launch
3M ago
KalVista 5.5M share Secondary priced at $10.00
Premium
The Fly
KalVista 5.5M share Secondary priced at $10.00
3M ago
KalVista presents data showing sebetralstat effectiveness in reducing anxiety
Premium
The Fly
KalVista presents data showing sebetralstat effectiveness in reducing anxiety
4M ago
KalVista names Brian Piekos as CFO
PremiumThe FlyKalVista names Brian Piekos as CFO
5M ago
KalVista presents sebetralstat data at Bradykinin Symposium 2024
Premium
The Fly
KalVista presents sebetralstat data at Bradykinin Symposium 2024
5M ago
KalVista reports Q1 EPS (87c), consensus (91c)
Premium
The Fly
KalVista reports Q1 EPS (87c), consensus (91c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100